FDA unveils new rare disease pilot program to increase agency-sponsor communications - Endpoints News
endpts.comSubmitted by endpointsnews6292 in business
The FDA on Friday unveiled new details around a rare disease pilot program that seeks to increase rapid, ad-hoc communications between six sponsors working on such treatments and the agency. Between Jan. 2, 2024 and March 1, 2024, pilot program participants w…